Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Wages, Salaries and Other
Others
Ratios

Coeptis Therapeutics Holdings (COEP) Non Operating Income (2021 - 2025)

Coeptis Therapeutics Holdings (COEP) has 5 years of Non Operating Income data on record, last reported at $151993.0 in Q3 2025.

  • For Q3 2025, Non Operating Income rose 194.8% year-over-year to $151993.0; the TTM value through Sep 2025 reached $96440.0, up 144.59%, while the annual FY2024 figure was $152109.0, 168.99% up from the prior year.
  • Non Operating Income reached $151993.0 in Q3 2025 per COEP's latest filing, up from -$338460.0 in the prior quarter.
  • Across five years, Non Operating Income topped out at $14.2 million in Q1 2021 and bottomed at -$3.5 million in Q1 2022.
  • Average Non Operating Income over 5 years is $602974.9, with a median of $8063.0 recorded in 2024.
  • The widest YoY moves for Non Operating Income: up 318.46% in 2024, down 225828.57% in 2024.
  • A 5-year view of Non Operating Income shows it stood at -$1.6 million in 2021, then skyrocketed by 104.62% to $76108.0 in 2022, then plummeted by 358.73% to -$196911.0 in 2023, then soared by 187.09% to $171493.0 in 2024, then fell by 11.37% to $151993.0 in 2025.
  • Per Business Quant database, its latest 3 readings for Non Operating Income were $151993.0 in Q3 2025, -$338460.0 in Q2 2025, and $111414.0 in Q1 2025.